The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 16, 2024
Filed:
Oct. 26, 2020
Applicants:
The Trustees of Columbia University IN the City of New York, New York, NY (US);
Levo Therapeutics, Inc., Skokie, IL (US);
Inventors:
Lisa Cole Burnett, Chicago, IL (US);
Dieter Egli, New York, NY (US);
Rudolph L Leibel, New York, NY (US);
Sara Cotter, New York, NY (US);
Assignees:
The Trustees of Columbia University in the City of New York, New York, NY (US);
Levo Therapeutics, Inc., Skokie, IL (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/366 (2006.01); A61K 31/277 (2006.01); A61K 31/352 (2006.01); A61K 31/4015 (2006.01); A61K 31/403 (2006.01); A61K 31/4035 (2006.01); A61K 31/4162 (2006.01); A61K 31/426 (2006.01); A61K 31/437 (2006.01); A61K 31/4375 (2006.01); A61K 31/44 (2006.01); A61K 31/454 (2006.01); A61K 31/517 (2006.01); A61K 31/519 (2006.01); A61K 31/522 (2006.01); A61K 31/5513 (2006.01); A61K 31/69 (2006.01); A61K 38/08 (2019.01); A61K 38/095 (2019.01); A61K 45/06 (2006.01); A61P 43/00 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/366 (2013.01); A61K 31/277 (2013.01); A61K 31/352 (2013.01); A61K 31/4015 (2013.01); A61K 31/403 (2013.01); A61K 31/4035 (2013.01); A61K 31/4162 (2013.01); A61K 31/426 (2013.01); A61K 31/437 (2013.01); A61K 31/4375 (2013.01); A61K 31/44 (2013.01); A61K 31/454 (2013.01); A61K 31/517 (2013.01); A61K 31/519 (2013.01); A61K 31/522 (2013.01); A61K 31/5513 (2013.01); A61K 31/69 (2013.01); A61K 38/08 (2013.01); A61K 38/095 (2019.01); A61K 45/06 (2013.01); A61P 43/00 (2018.01); A61K 38/00 (2013.01);
Abstract
The present invention relates to methods for regulating prohormone convertase (PC1) and compounds and treatments which increase PC1 levels, for treating Prader-Willi Syndrome (PWS).